GlaxoSmithKline calls £100m global media review

LONDON – GlaxoSmithKline is reviewing its international media planning and buying arrangements, not including the US, worth an estimated £100m.

No Responses to “GlaxoSmithKline calls £100m global media review”

Post a Comment